Use Of Tolterodine In Children With Neurogenic Detrusor Overactivity: Relationship Between Dose And Urodynamic Response
Main Category: Urology / NephrologyAlso Included In: Pediatrics / Children's Health
Article Date: 28 Aug 2008 - 3:00 PST
UroToday.com - This study by Dr. Pramod Reddy et al. evaluated the use of tolterodine in children with neurogenic detrusor overactivity. The efficacy of the drug was evaluated urodynamically and using parent-completed 3-day bladder diaries. The study was done prospectively. They received drug formulation and dosing based on age.
They found that functional bladder capacity increased within one year in the younger patients but not in the older patients. The first contraction in detrusor leak point pressure did not change in any age group. The number of incontinence episodes decreased for all the patients, as did the number of catheterizations utilized in the 24-hour period to keep dry. The mean volume per catheterization increased in all subjects. Seven of the 30 subjects who were enrolled showed treatment-related adverse events.
The group concluded that tolterodine formulations were effective and well tolerated in children with neurogenic detrusor overactivity. This is a helpful first step since the long-acting tolterodine might play a role for these children once the short-acting dose is tolerated.
Ellsworth PI, Borgstein NG, Nijman RJ, Reddy PP
J Urol. 2005 Oct;174(4 Pt 2):1647-51
doi:10.1097/01.ju.0000176622.81796.89
Reported by UroToday.com Medical Editor Pasquale Casale, MD
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to: www.urotoday.com
Copyright © 2008 - UroToday
|
Please rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
| Back to top | Back to front page | List of All Medical Articles |
| Privacy Policy | Terms and Conditions | © 2009 MediLexicon International Ltd |




